October 2019

Starting Saturday October 26th  primary care physicians across the country will engage in education on the emerging health crisis…

The US Food and Drug Administration (“FDA”) provided a report to Congress, entitled Pediatric Labeling of Orphan Drugs, detailing…

The Federal Trade Commission (“FTC”) sent letters to several law firms and marketing companies, warning them that advertisements…

Recently, the Justice Department Office of Inspector General (“OIG”) released a report criticizing the regulatory activities and…

The US Food and Drug Administration (“FDA”) Office of Prescription Drug Promotion (“OPDP”) sent a Warning Letter to Galt…

California Governor Gavin Newsom recently signed three legislative bills into law, all aimed at lowering the cost of prescription…

The current U.S. opioid epidemic has been branded as “the worst drug crisis in America’s history” and a “man-made plague.” …

The US Food and Drug Administration (“FDA”) released quarterly data on two programs intended to increase generic competition and…

Recently, the US Food and Drug Administration Office of Prescription Drug Promotion (“OPDP”) sent a warning letter to Metuchen…

It has been several months since the United States Food and Drug Administration (FDA) approved Novartis’ gene therapy drug…